Front Page
July 19, 2022
REGISTER NOW! ADAI Symposium: High-THC Cannabis in Legal Regulated Markets
REGISTRATION IS NOW OPEN for our fall cannabis symposium, to be held both online and in-person at the UW Tower in Seattle, WA. This year’s event, High THC Cannabis in Legal Regulated Markets: Documenting Risks & Exploring Solutions for Non-Medical Use, will focus on the short and long-term risks of high-THC products, including conversations about policy-focused solutions and…
July 13, 2022
New Article: Community-Based “Meds-First” Model of Care for Opioid Use Disorder Study
This paper, by ADAI Principal Research Scientist Caleb Banta-Green and colleagues, describes the Community-Based “Meds First” model of care for opioid use disorder treatment and an ongoing study. The Meds First model of care is based on same-day (typically) access to buprenorphine; walk-in, non-appointment support with a nurse care manager and care navigator; no…
July 6, 2022
New Article: Intervention to Address Sexual Risk Behavior in SUD Treatment Increases Conversations About Sex Between Counselors & Patients
High-risk sex, like sex with multiple partners, without condoms, or transactional or commercial sex, is a risk factor in people who have substance use disorders (SUDs). Interventions in SUD treatment settings aimed at reducing sexual risk behavior can help, but so far haven’t been consistently effective. This new article in Journal of Substance Abuse Treatment…
June 29, 2022
New Look for StopOverdose.org!
ADAI and the CEDEER team are excited to launch a new version of our website, StopOverdose.org. Check out the webpage and let us know what you think! Features of the new site include: Improved navigation and organization Better accessibility Translation into 20 different languages (by Google Translate) The redesign work was done by Heather Larson at Day…
June 27, 2022
New Article: Insights into a Recovery Community Center Model: Interviews with Staff from Recovery Café
Key findings: Participants noted that having a safe, welcoming place was important, as was having access to food, community, and resources. Participants also highlighted that having opportunities to contribute to the Café and areas for growth were essential components. Overview In Spring 2020, focus groups and interviews were done virtually with ten Staff and six…
June 22, 2022
Care Navigation at Harm Reduction Programs: Community-Based “Meds First” Buprenorphine Program Preliminary Data
ADAI Report by Susan Kingston & Caleb Banta-Green In 2019, the Addictions, Drug & Alcohol Institute (ADAI) at the University of Washington launched the “Meds First” program to provide onsite, low-barrier access to buprenorphine in partnership with six syringe services programs across WA State. A key component of the Meds First service model was the…
June 17, 2022
ADAI in the News: High THC Concentration Products (Bia Carlini) and Safer Smoking Kits (Caleb Banta-Green)
High THC Concentration Products are a “Time Bomb” ADAI Research Scientist Beatriz Carlini, PhD, MPH was interviewed for an article in The Times (UK) about high THC concentration products and how it’s a “time bomb” in terms of its potential effects on the mental health of people who use it. “We are not paying attention…
June 15, 2022
ADAI Job Openings: 2 Continuing Education Coordinators
ADAI is currently seeking applicants for two open positions. (Want to get notified first whenever we have a position open? Sign up for our ADAI Job Openings mailing list!) Continuing Education Coordinator As a team member of the Center for Community-engaged Drug Education, Epidemiology and Research (CEDEER), the Continuing Education Coordinator will actively contribute to a growing…
June 13, 2022
Webinar June 30: Emergency Department-Initiated Buprenorphine for Opioid Use Disorder
June 30, 2022 | 11:00am – 12:30pm (PT) | 1.5 CME/CE available | Register here! Please join the Northwest ATTC, the Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network for our next joint webinar, June 30, 2022 (11am-12:30pm PT). The goal of the ATTC/CTN webinar series is to help…
June 6, 2022
How to Get Naloxone in WA State
Do you have naloxone (a.k.a. Narcan) in your first aid kit? This medication is given when an opioid overdose happens and can help save someone’s life. Anyone who uses opioids (even if they are prescribed by a physician) or who has friends or family who do should have naloxone on hand just in case. Additionally,…
Previous page Next page
